_id
69148d4dccc777a4e85d9a9a
Ticker
PHRX
Name
Pharmagen Inc
Exchange
OTCCE
Address
9337 Fraser Avenue, Silver Spring, MD, United States, 20910
Country
USA
Sector
Healthcare
Industry
Medical Distribution
Currency
USD
Website
https://www.pharmageninc.com
Description
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
Last Close
-
Volume
-
Current Price
0
Change
0
Last Updated
2026-01-06T09:11:06.280Z
Image
-
Ipo Date
-
Market Cap
5170
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2014-03-31
Revenue
1319464
Cost Of Revenue
582990
Gross Profit
736474
Operating Expenses
1729987
Operating Income
-410523
Interest Expense
644621
Pretax Income
-712602
Net Income
-712602
Eps
-
Dividends Per Share
0
Shares Outstanding
517075954
Income Tax Expense
0
EBITDA
-
Operating Margin
-31.112860979913055
Total Other Income Expense Net
-302079
Cash
264673
Short Term Investments
0
Receivables
325780
Inventories
169877
Total Current Assets
836995
Property Plant Equipment
423784
Total Assets
1279505
Payables
1726715
Short Term Debt
0
Long Term Debt
520000
Total Liabilities
9083598
Equity
-8034193
Bs_currency_symbol
USD
Depreciation
30151
Change In Working Capital
-
Cash From Operations
48359
Capital Expenditures
62166
Cash From Investing
-62166
Cash From Financing
52497
Net Change In Cash
38690
Cf_currency_symbol
USD
PE
-
PB
-
ROE
8.869615156120846
ROA
-55.69356899738571
FCF
-13807
Fcf Percent
-0.010464097542638526
Piotroski FScore
2
Health Score
33
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2014-03-31
Quarters > 0 > income Statement > revenue
1319464
Quarters > 0 > income Statement > cost Of Revenue
582990
Quarters > 0 > income Statement > gross Profit
736474
Quarters > 0 > income Statement > operating Expenses
1729987
Quarters > 0 > income Statement > operating Income
-410523
Quarters > 0 > income Statement > interest Expense
644621
Quarters > 0 > income Statement > pretax Income
-712602
Quarters > 0 > income Statement > net Income
-712602
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
0
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-31.112860979913055
Quarters > 0 > income Statement > total Other Income Expense Net
-302079
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
264673
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
325780
Quarters > 0 > balance Sheet > inventories
169877
Quarters > 0 > balance Sheet > total Current Assets
836995
Quarters > 0 > balance Sheet > property Plant Equipment
423784
Quarters > 0 > balance Sheet > total Assets
1279505
Quarters > 0 > balance Sheet > payables
1726715
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
520000
Quarters > 0 > balance Sheet > total Liabilities
9083598
Quarters > 0 > balance Sheet > equity
-8034193
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-712602
Quarters > 0 > cash Flow > depreciation
30151
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
48359
Quarters > 0 > cash Flow > capital Expenditures
62166
Quarters > 0 > cash Flow > cash From Investing
-62166
Quarters > 0 > cash Flow > cash From Financing
52497
Quarters > 0 > cash Flow > net Change In Cash
38690
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
8.869615156120846
Quarters > 0 > ratios > ROA
-55.69356899738571
Quarters > 0 > ratios > FCF
-13807
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.010464097542638526
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2013-12-31
Quarters > 1 > income Statement > revenue
1043062
Quarters > 1 > income Statement > cost Of Revenue
401369
Quarters > 1 > income Statement > gross Profit
641693
Quarters > 1 > income Statement > operating Expenses
1818952
Quarters > 1 > income Statement > operating Income
-775890
Quarters > 1 > income Statement > interest Expense
957722
Quarters > 1 > income Statement > pretax Income
-2310621
Quarters > 1 > income Statement > net Income
-2310621
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
0
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-74.38579873487865
Quarters > 1 > income Statement > total Other Income Expense Net
-1534731
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
225983
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
367848
Quarters > 1 > balance Sheet > inventories
136969
Quarters > 1 > balance Sheet > total Current Assets
879305
Quarters > 1 > balance Sheet > property Plant Equipment
383022
Quarters > 1 > balance Sheet > total Assets
1282300
Quarters > 1 > balance Sheet > payables
1379421
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
500000
Quarters > 1 > balance Sheet > total Liabilities
8868814
Quarters > 1 > balance Sheet > equity
-7716614
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2310621
Quarters > 1 > cash Flow > depreciation
33619
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-31896
Quarters > 1 > cash Flow > capital Expenditures
29041
Quarters > 1 > cash Flow > cash From Investing
-29041
Quarters > 1 > cash Flow > cash From Financing
98563
Quarters > 1 > cash Flow > net Change In Cash
37626
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
29.943457065495306
Quarters > 1 > ratios > ROA
-180.19348046478981
Quarters > 1 > ratios > FCF
-60937
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.05842126354905078
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2013-09-30
Quarters > 2 > income Statement > revenue
1073661
Quarters > 2 > income Statement > cost Of Revenue
400640
Quarters > 2 > income Statement > gross Profit
673021
Quarters > 2 > income Statement > operating Expenses
1786910
Quarters > 2 > income Statement > operating Income
-713249
Quarters > 2 > income Statement > interest Expense
732212
Quarters > 2 > income Statement > pretax Income
-1347255
Quarters > 2 > income Statement > net Income
-1347255
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
0
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-66.43149001407335
Quarters > 2 > income Statement > total Other Income Expense Net
-634006
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
188357
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
606531
Quarters > 2 > balance Sheet > inventories
162572
Quarters > 2 > balance Sheet > total Current Assets
1426746
Quarters > 2 > balance Sheet > property Plant Equipment
381383
Quarters > 2 > balance Sheet > total Assets
3025230
Quarters > 2 > balance Sheet > payables
1019170
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
750000
Quarters > 2 > balance Sheet > total Liabilities
9035093
Quarters > 2 > balance Sheet > equity
-6012863
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1347255
Quarters > 2 > cash Flow > depreciation
26728
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-123850
Quarters > 2 > cash Flow > capital Expenditures
7700
Quarters > 2 > cash Flow > cash From Investing
-7700
Quarters > 2 > cash Flow > cash From Financing
114875
Quarters > 2 > cash Flow > net Change In Cash
-16675
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
22.406214809816888
Quarters > 2 > ratios > ROA
-44.53396931803532
Quarters > 2 > ratios > FCF
-131550
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.12252470751941255
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2013-06-30
Quarters > 3 > income Statement > revenue
974994
Quarters > 3 > income Statement > cost Of Revenue
275656
Quarters > 3 > income Statement > gross Profit
699338
Quarters > 3 > income Statement > operating Expenses
1317373
Quarters > 3 > income Statement > operating Income
-342379
Quarters > 3 > income Statement > interest Expense
684103
Quarters > 3 > income Statement > pretax Income
-1500945
Quarters > 3 > income Statement > net Income
-1500945
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
0
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-35.11601097032392
Quarters > 3 > income Statement > total Other Income Expense Net
-1158566
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
205032
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
647345
Quarters > 3 > balance Sheet > inventories
192980
Quarters > 3 > balance Sheet > total Current Assets
1356514
Quarters > 3 > balance Sheet > property Plant Equipment
74302
Quarters > 3 > balance Sheet > total Assets
2649164
Quarters > 3 > balance Sheet > payables
883482
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
750000
Quarters > 3 > balance Sheet > total Liabilities
7767841
Quarters > 3 > balance Sheet > equity
-5121677
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1500945
Quarters > 3 > cash Flow > depreciation
20353
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-375706
Quarters > 3 > cash Flow > capital Expenditures
3700
Quarters > 3 > cash Flow > cash From Investing
-3700
Quarters > 3 > cash Flow > cash From Financing
-62520
Quarters > 3 > cash Flow > net Change In Cash
-441926
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
29.305733258852516
Quarters > 3 > ratios > ROA
-56.6573077393472
Quarters > 3 > ratios > FCF
-379406
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.38913675366207384
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2013-12-31
Annuals > 0 > income Statement > revenue
4813048
Annuals > 0 > income Statement > cost Of Revenue
1767836
Annuals > 0 > income Statement > gross Profit
3045212
Annuals > 0 > income Statement > operating Expenses
6972076
Annuals > 0 > income Statement > operating Income
-2159028
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-6000614
Annuals > 0 > income Statement > net Income
-6000614
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
0
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-44.8578115156965
Annuals > 0 > income Statement > total Other Income Expense Net
-3841586
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
225983
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
367848
Annuals > 0 > balance Sheet > inventories
136969
Annuals > 0 > balance Sheet > total Current Assets
879305
Annuals > 0 > balance Sheet > property Plant Equipment
383022
Annuals > 0 > balance Sheet > total Assets
1282300
Annuals > 0 > balance Sheet > payables
1379421
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
500000
Annuals > 0 > balance Sheet > total Liabilities
8868814
Annuals > 0 > balance Sheet > equity
-7716614
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6000614
Annuals > 0 > cash Flow > depreciation
99347
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-692071
Annuals > 0 > cash Flow > capital Expenditures
56701
Annuals > 0 > cash Flow > cash From Investing
-56701
Annuals > 0 > cash Flow > cash From Financing
652199
Annuals > 0 > cash Flow > net Change In Cash
-96573
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
77.7622672327526
Annuals > 0 > ratios > ROA
-467.9571083209857
Annuals > 0 > ratios > FCF
-748772
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.15557127209202984
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2012-12-31
Annuals > 1 > income Statement > revenue
4260610
Annuals > 1 > income Statement > cost Of Revenue
2996106
Annuals > 1 > income Statement > gross Profit
1264504
Annuals > 1 > income Statement > operating Expenses
6356865
Annuals > 1 > income Statement > operating Income
-2096255
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-2771268
Annuals > 1 > income Statement > net Income
-2771268
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
0
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-49.20081866211646
Annuals > 1 > income Statement > total Other Income Expense Net
-675013
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
322556
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
635599
Annuals > 1 > balance Sheet > inventories
147373
Annuals > 1 > balance Sheet > total Current Assets
1585807
Annuals > 1 > balance Sheet > property Plant Equipment
90865
Annuals > 1 > balance Sheet > total Assets
2897497
Annuals > 1 > balance Sheet > payables
779065
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
1252751
Annuals > 1 > balance Sheet > total Liabilities
5589258
Annuals > 1 > balance Sheet > equity
-2694761
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2771268
Annuals > 1 > cash Flow > depreciation
32813
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-2181638
Annuals > 1 > cash Flow > capital Expenditures
93995
Annuals > 1 > cash Flow > cash From Investing
-173995
Annuals > 1 > cash Flow > cash From Financing
2639531
Annuals > 1 > cash Flow > net Change In Cash
283898
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
102.83910150102365
Annuals > 1 > ratios > ROA
-95.64351576550382
Annuals > 1 > ratios > FCF
-2275633
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.5341096697421261
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2011-12-31
Annuals > 2 > income Statement > revenue
862750
Annuals > 2 > income Statement > cost Of Revenue
453553
Annuals > 2 > income Statement > gross Profit
409197
Annuals > 2 > income Statement > operating Expenses
1145294
Annuals > 2 > income Statement > operating Income
-282544
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-296810
Annuals > 2 > income Statement > net Income
-296810
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
0
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-32.74923210663576
Annuals > 2 > income Statement > total Other Income Expense Net
-14266
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
38658
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
211549
Annuals > 2 > balance Sheet > inventories
12144
Annuals > 2 > balance Sheet > total Current Assets
274919
Annuals > 2 > balance Sheet > property Plant Equipment
29683
Annuals > 2 > balance Sheet > total Assets
304602
Annuals > 2 > balance Sheet > payables
198253
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
674351
Annuals > 2 > balance Sheet > equity
-372749
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-296810
Annuals > 2 > cash Flow > depreciation
27237
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-254539
Annuals > 2 > cash Flow > capital Expenditures
56920
Annuals > 2 > cash Flow > cash From Investing
-56920
Annuals > 2 > cash Flow > cash From Financing
343305
Annuals > 2 > cash Flow > net Change In Cash
31846
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
79.62730953000545
Annuals > 2 > ratios > ROA
-97.44190780099935
Annuals > 2 > ratios > FCF
-311459
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.36100724427702113
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2010-12-31
Annuals > 3 > income Statement > revenue
75305
Annuals > 3 > income Statement > cost Of Revenue
9255
Annuals > 3 > income Statement > gross Profit
66050
Annuals > 3 > income Statement > operating Expenses
77416
Annuals > 3 > income Statement > operating Income
-2111
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-9328
Annuals > 3 > income Statement > net Income
-9328
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-2.803266715357546
Annuals > 3 > income Statement > total Other Income Expense Net
-7217
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
6812
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
45210
Annuals > 3 > balance Sheet > inventories
55764
Annuals > 3 > balance Sheet > total Current Assets
107786
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
107786
Annuals > 3 > balance Sheet > payables
53795
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
186588
Annuals > 3 > balance Sheet > equity
-78802
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-9328
Annuals > 3 > cash Flow > depreciation
27237
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
7049
Annuals > 3 > cash Flow > capital Expenditures
56920
Annuals > 3 > cash Flow > cash From Investing
-56920
Annuals > 3 > cash Flow > cash From Financing
-4301
Annuals > 3 > cash Flow > net Change In Cash
2748
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
11.837263013629096
Annuals > 3 > ratios > ROA
-8.65418514463845
Annuals > 3 > ratios > FCF
-49871
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.6622535024234778
Annuals > 3 > health Score
30
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
8.869615156120846
Profitability > metrics > ROA
-85.1381429996595
Profitability > metrics > Net Margin
-0.5400693008676251
Profitability > final Score
18
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.6368439749868527
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.4847325702272813
Liquidity > metrics > Quick Ratio
0.38635096121826706
Liquidity > final Score
29
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
27
Prev Risks > 1
26
Prev Risks > 2
28
Prev Liquidities > 0
37
Prev Liquidities > 1
85
Prev Liquidities > 2
88
Updated At
2026-01-20T22:23:38.952Z
Earnings History > 0 > period
2024-09-30
Earnings History > 0 > report Date
2024-11-27
Earnings History > 0 > date
2024-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-08-28
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-03-31
Earnings History > 2 > report Date
2024-05-29
Earnings History > 2 > date
2024-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-12-31
Earnings History > 3 > report Date
2024-02-28
Earnings History > 3 > date
2023-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-09-30
Earnings History > 4 > report Date
2023-11-29
Earnings History > 4 > date
2023-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-06-30
Earnings History > 5 > report Date
2023-08-30
Earnings History > 5 > date
2023-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-05-31
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-12-31
Earnings History > 7 > report Date
2023-03-01
Earnings History > 7 > date
2022-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-09-30
Earnings History > 8 > report Date
2022-11-30
Earnings History > 8 > date
2022-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-06-30
Earnings History > 9 > report Date
2022-08-31
Earnings History > 9 > date
2022-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-03-31
Earnings History > 10 > report Date
2022-06-01
Earnings History > 10 > date
2022-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-12-31
Earnings History > 11 > report Date
2022-03-02
Earnings History > 11 > date
2021-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-09-30
Earnings History > 12 > report Date
2021-12-01
Earnings History > 12 > date
2021-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-06-30
Earnings History > 13 > report Date
2021-09-01
Earnings History > 13 > date
2021-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-03-31
Earnings History > 14 > report Date
2021-06-02
Earnings History > 14 > date
2021-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2020-12-31
Earnings History > 15 > report Date
2021-03-03
Earnings History > 15 > date
2020-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2020-09-30
Earnings History > 16 > report Date
2020-12-02
Earnings History > 16 > date
2020-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-06-30
Earnings History > 17 > report Date
2020-09-02
Earnings History > 17 > date
2020-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-03-31
Earnings History > 18 > report Date
2020-06-03
Earnings History > 18 > date
2020-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2019-12-31
Earnings History > 19 > report Date
2020-02-26
Earnings History > 19 > date
2019-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-11-27
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-06-30
Earnings History > 21 > report Date
2019-08-28
Earnings History > 21 > date
2019-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-03-31
Earnings History > 22 > report Date
2019-05-29
Earnings History > 22 > date
2019-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2018-12-31
Earnings History > 23 > report Date
2019-02-27
Earnings History > 23 > date
2018-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2018-09-30
Earnings History > 24 > report Date
2018-11-28
Earnings History > 24 > date
2018-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
0
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-06-30
Earnings History > 25 > report Date
2018-08-29
Earnings History > 25 > date
2018-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
0
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-03-31
Earnings History > 26 > report Date
2018-05-30
Earnings History > 26 > date
2018-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2017-12-31
Earnings History > 27 > report Date
2018-02-28
Earnings History > 27 > date
2017-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-03-31
Earnings History > 28 > report Date
2014-05-15
Earnings History > 28 > date
2014-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
0
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2013-12-31
Earnings History > 29 > report Date
2014-03-31
Earnings History > 29 > date
2013-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0017
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0017
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2013-09-30
Earnings History > 30 > report Date
2013-11-14
Earnings History > 30 > date
2013-09-30
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.007
Earnings History > 30 > eps Estimate
-0.0024
Earnings History > 30 > eps Difference
-0.0046
Earnings History > 30 > surprise Percent
-191.6667
Earnings History > 31 > period
2013-06-30
Earnings History > 31 > report Date
2013-08-14
Earnings History > 31 > date
2013-06-30
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0037
Earnings History > 31 > eps Estimate
-0.0025
Earnings History > 31 > eps Difference
-0.0012
Earnings History > 31 > surprise Percent
-48
Earnings History > 32 > period
2013-03-31
Earnings History > 32 > report Date
2013-06-30
Earnings History > 32 > date
2013-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.0039
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.0039
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2012-12-31
Earnings History > 33 > report Date
2013-03-31
Earnings History > 33 > date
2012-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.0022
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.0022
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2012-09-30
Earnings History > 34 > report Date
2012-12-31
Earnings History > 34 > date
2012-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.0025
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.0025
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2012-06-30
Earnings History > 35 > report Date
2012-09-30
Earnings History > 35 > date
2012-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.0028
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-0.0028
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2012-03-31
Earnings History > 36 > report Date
2012-06-30
Earnings History > 36 > date
2012-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.0013
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-0.0013
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2011-12-31
Earnings History > 37 > report Date
2012-03-31
Earnings History > 37 > date
2011-12-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.0012
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-0.0012
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2011-09-30
Earnings History > 38 > report Date
2011-12-31
Earnings History > 38 > date
2011-09-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
0
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2011-06-30
Earnings History > 39 > report Date
2011-09-30
Earnings History > 39 > date
2011-06-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.0008
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
-0.0008
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2011-03-31
Earnings History > 40 > report Date
2011-06-30
Earnings History > 40 > date
2011-03-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.0006
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
-0.0006
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2010-12-31
Earnings History > 41 > report Date
2011-03-31
Earnings History > 41 > date
2010-12-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.0001
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
-0.0001
Earnings History > 41 > surprise Percent
-
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APharmaDrug takes 19.9% stake in Canurta and restructures capital to advance botanical drug portfolio MSN
Read more →Key deals this week: Qorvo, Chewy, Sotherly Hotels, Novartis, CSG Systems, and more (NVS:NYSE) Seeking Alpha
Read more →Showing 2 of 9
(Last Updated 2014-03-31)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Pharmagen Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2014-03-31)
(Last Updated 2014-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2014-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2014-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.